Navigation Links
Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
Date:7/9/2013

SANTA CLARA, Calif., July 9, 2013 /PRNewswire/ -- NextBio, whose Big Data technology enables users to apply genomic data from disparate sources in novel and useful ways across life sciences research, today announced that Boehringer Ingelheim has signed a multi-year renewal agreement to the NextBio Research Platform. The new agreement also expands the user base for NextBio across Boehringer Ingelheim's global research organization.

(Logo: http://photos.prnewswire.com/prnh/20130402/SF86976LOGO)

"Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies and has been a user of NextBio Research for the past year," said Saeid Akhtari, NextBio President and Chief Executive Officer. "This expanded license and broadened access to the NextBio Research platform is a strong endorsement of our technology's value for enabling life scientists to quickly examine and understand their data in the context of published research worldwide.

"NextBio Research provides a comprehensive platform for exploratory, preclinical and early translational research in drug discovery and biotechnology research," Mr. Akhtari added. "Integrating proprietary analysis results with extensive curated content, NextBio enhances researchers' ability to design experiments, test hypotheses and validate results, leading to better target analysis, understanding of disease mechanisms, and analysis of results across species."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high the
'/>"/>

SOURCE NextBio
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
2. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
3. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
4. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
6. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
7. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
8. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
9. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
10. Boehringer Ingelheim Cares Foundation Launches Online Giving Report
11. Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... has completed the sale to Galderma of all rights ... held by Valeant for $1.4 billion in cash, pursuant ... recently completed its acquisition of Galderma. ... products to a company that is firmly committed to ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation (NYSE: ... directors has approved a quarterly dividend of $0.275 (27.5 cents) ... payable on August 1, 2014, to holders of record on ... CVS Caremark is dedicated to helping people on their ... in the United States . Through the ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... Employment Awareness Month marks the 20th anniversary ... the cutting-edge voice of disability culture in America. ... and edited by staff and freelancers with disabilities, encourages ... while simultaneously reflecting the vibrant world of disability-related arts, ...
... PHILADELPHIA, Oct. 21 Sanovia, a leading provider ... it has been selected by HealthSpring, Inc. to ... HealthSpring, one of the largest Medicare Advantage coordinated ... reinforces Sanovia,s leadership in delivering pharmaceutical prior authorization ...
Cached Medicine Technology:Award-Winning Disability Lifestyle Magazine Celebrates 20 Years of Publication - And 20 Years of Employing People with Disabilities 2Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring 2Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring 3
(Date:7/13/2014)... (PRWEB) July 13, 2014 Hope Palliative & ... monthly grief support group at the Tamarack Senior Living Community ... held at 10:30 A.M. on the 3rd Wednesdays of every ... 2014 at the Tamarack Community located at 55 S. Greeley ... bereaved individuals and there is no cost for the group. ...
(Date:7/12/2014)... July 13, 2014 According to the ... (Land Systems, Airborne Systems, and Naval Systems) - Global ... MarketsandMarkets, Security and Surveillance Radar market are estimated to ... register a CAGR of 5.97% to reach $8.61 billion ... tables with 47 figures spread through 161 pages and ...
(Date:7/12/2014)... Fresh off their respective performances in the 2014 World ... 5th at Sun Life Stadium in an international friendly. The ... brightest stars in the world of football in Colombian and ... to some of the best talent in the world in ... best team in the world according to the Fédération Internationale ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... research report, ‘cognitive assessment and training’ is ... monitor, assess, train, or enhance cognitive functions. ... such as in dementia screening, clinical trials, ... classroom learning, self assessment, brain training, and ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Casinos ... years, despite rising competition from international and online casinos. ... 2.9% over the five years through 2014-15. Greater per ... demanding more gaming services. Rises in discretionary income levels ... more money on non-essential items such as casino gambling ...
Breaking Medicine News(10 mins):Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 2Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 5Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... All," Interaction Associates Senior Consultant Jay Gordon Cone provides a model ... teams are high-performing - and decide what to do if they,re ... ... of the work of business today takes place in team environments. ...
... Journal of Hematology by scientists from the Fudan-Cinpathogen ... Shanghai, in collaboration with the University of ... subtypes of chronic lymphoid neoplasms are not as ... Diagnosis and classification were performed by a single ...
... with current US treatment guidelines to start ... 80% of patients may need multiple medications to help them reach ... blood pressure goals, - Single-pill ... could help patients reach treatment goals faster, - Diovan HCT and ...
... or at the neighborhood pool, diving is one of the ... of people do it* and every four years during the ... you that researchers are just now delving into the dangers ... competing at the highest levels of diving takes persistence. Day ...
... children and a highly touted botanical extract (COLD-fX) show ... Canadian cold and flu remedy. The results appear in ... the official journal of the American Academy of Pediatrics. ... was conducted in collaboration with the University of Alberta ...
... Today, the University,HealthSystem Consortium (UHC) announced that ... medical center (AMC) in Jackson, has,been added to ... chain,participants., "Moving to UHC for our group ... strategic partner that is committed to meeting our,unique ...
Cached Medicine News:Health News:New White Paper by Performance Improvement Innovator Interaction Associates Helps Business Leaders Assess Team Effectiveness 2Health News:Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 3Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 4Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 5Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 6Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 7Health News:First national study of diving-related injuries 2Health News:First national study of diving-related injuries 3Health News:Canadian study of colds and kids: Positive safety results for ginseng extract 2Health News:University of Mississippi Health Care Selects UHC for Group Purchasing Services 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: